Chris Collins Lectures
Chris Collins was made an Honorary Member of EBSA for his outstanding contribution to biosafety at the Vienna meeting of EBSA in March 2002. In further recognition of his extraordinary achievements the keynote lecture at the annual EBSA conference has been named, since 2003, in his memory.
|Thinking Outside the Biosafety Box: BSL-2 Laboratory Design and Outfitting Safety and Health Pointers
Felix Gmünder, Global Biosafety Consultant, Basler & Hofmann, Switzerland
|We All Have a Bucket - Applying High Reliability Principles to Biosafety.
Tim Trevan, Chrome Biorisk Management, United States
|WHO GAP III roadmap to compliance for poliovirus-essential facilities
Toon De Kesel, Biorisk Expert, Febris, Belgium
|WHO biosafety manual revision - concept and consequences
Dr. Kazunobu Kojima, World Heath Organization (WHO)
|ustainable improvement of biosafety standards in low resource settings - a global challenge with many players
H. Sheeley, Public Health England, Salisbury/UK
U. Müller-Doblies, Epibiosafe, Knaphill/UK
|Biosafety and the global community - What's next?
J. Welch, Elizabeth R. Griffin Research Foundation, Kingsport, TN/USA
|My experiences with laboratory incidents and acquired infections: what goes wrong and how do we handle them?
A. Della-Porta, Biosecurity and Biocontainment International Consultants Pty. Ltd,
Chasing: influenza virus from 1918 Spanish flu exhumations to infection of volunteers in quarantine
|Aerosols to all that! From Pasteur to PCR, an alternative history of biosafety
A. Bennett, Health Protection Agency, Salisbury/UK
|Determinants of virulence in zoonotic and pandemic influenza viruses
Sander Herfst, Erasmus Medical Center, Rotterdam/NL
|Coping with biosafety in extreme filed conditions
Herwig Leirs, Universiteit Antwerpen/Belgium
Malcom Bennett, Liverpool University, United Kingdom
|The Genetic modification of blood forming stem cells
Christof von Kalle, Director National Center on Tumour Diseases, Heidelberg, Germany
|The Hague 2006
|Vaccine development for SARS, influenza and smallpox
Albert Osterhaus, Erasmus MC, The Netherlands
|Biological Safety Concepts of Genetically Modified Live Vaccines
Joachim Frey - University of Bern Institute for Veterinary Bacteriology, Bern, Switzerland
|Investigation of 1918 Spanish flu using permafrost burials and pathology lung blocks
Dr. Rod Daniels, National Institute for Medical Research, London, UK
Is our Focus to be more Biosafety or Biosecurity in the Era of Bio-Terrorism?